These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30699296)

  • 1. Predicting the Physical Stability of Amorphous Tenapanor Hydrochloride Using Local Molecular Structure Analysis, Relaxation Time Constants, and Molecular Modeling.
    Kothari S; Vippagunta RR
    Mol Pharm; 2019 Mar; 16(3):943-951. PubMed ID: 30699296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating an Amorphous Form Stabilization Mechanism for Tenapanor Hydrochloride: Crystal Structure Analysis Using X-ray Diffraction, NMR Crystallography, and Molecular Modeling.
    Nilsson Lill SO; Widdifield CM; Pettersen A; Svensk Ankarberg A; Lindkvist M; Aldred P; Gracin S; Shankland N; Shankland K; Schantz S; Emsley L
    Mol Pharm; 2018 Apr; 15(4):1476-1487. PubMed ID: 29490140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of counterions on the properties of amorphous atorvastatin salts.
    Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
    Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
    Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
    Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin.
    Graeser KA; Patterson JE; Rades T
    Curr Drug Deliv; 2009 Aug; 6(4):374-82. PubMed ID: 19534709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
    Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
    Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of hydrate forms of paroxetine HCl from the amorphous state: an evaluation of thermodynamic and experimental predictive approaches.
    Pina MF; Pinto JF; Sousa JJ; Craig DQ; Zhao M
    Int J Pharm; 2015 Mar; 481(1-2):114-24. PubMed ID: 25592956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
    Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
    Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K
    Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dielectric relaxation study on tramadol monohydrate and its hydrochloride salt.
    Kaminski K; Kaminska E; Adrjanowicz K; Grzybowiska K; Wlodarczyk P; Paluch M; Burian A; Ziolo J; Lepek P; Mazgalski J; Sawicki W
    J Pharm Sci; 2010 Jan; 99(1):94-106. PubMed ID: 19475556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Mono-, Di-, and Tri-Saccharides on the Stability and Crystallization of Amorphous Sucrose.
    Thorat AA; Forny L; Meunier V; Taylor LS; Mauer LJ
    J Food Sci; 2018 Nov; 83(11):2827-2839. PubMed ID: 30320406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheology and molecular mobility of amorphous blends of citric acid and paracetamol.
    Hoppu P; Hietala S; Schantz S; Juppo AM
    Eur J Pharm Biopharm; 2009 Jan; 71(1):55-63. PubMed ID: 18656536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous Protic Ionic Systems as Promising Active Pharmaceutical Ingredients: The Case of the Sumatriptan Succinate Drug.
    Wojnarowska Z; Knapik J; Rams-Baron M; Jedrzejowska A; Paczkowska M; Krause A; Cielecka-Piontek J; Jaworska M; Lodowski P; Paluch M
    Mol Pharm; 2016 Mar; 13(3):1111-22. PubMed ID: 26836258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.